Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Tuberculosis (TB) cases and deaths in the United States fluctuated substantially during the COVID-19 pandemic. We analyzed multiple data sources to understand the factors contributing to these changes and estimated future TB trends.
Methods
We identified four mechanisms potentially contributing to observed TB trends during 2020– 2023: immigration, respiratory contact rates, rates of accurate diagnosis and treatment initiation, and mortality rates for persons with TB disease. We employed a Bayesian approach to synthesize evidence on how these mechanisms changed during the pandemic and how they might have combined to produce observed 2020–2023 TB data, using a transmission-dynamic model to link mechanisms to TB outcomes. We also simulated a no-pandemic counterfactual scenario that assumed mechanisms followed pre-pandemic trends. We estimated TB outcomes associated with the pandemic until 2035 to capture lagged effects. We evaluated additional scenarios to estimate the individual effect of each mechanism.
Results
Over the 2020–2035 study period, we estimate an additional 2,784 (95% uncertainty interval: 2,164–3,461) TB cases and 1,138 (1,076–1,201) TB deaths in the United States associated with changes occurring during the COVID-19 pandemic. The four mechanisms had offsetting effects – decreases in TB diagnosis rates and increases in TB mortality rates led to more TB deaths, while reductions in contact rates reduced TB deaths. Immigration changes initially reduced TB deaths, but increased deaths over time.
Discussion
While the direct impacts of the COVID-19 pandemic occurred between 2020–2023, these changes may continue to influence TB incidence and mortality in future years.
Summary
The COVID-19 pandemic disrupted steady declines in U.S. tuberculosis rates. Despite sharp decreases in TB cases over 2020–2021, we projected there would be 2,784 additional TB cases and 1,138 additional TB deaths during 2020–2035 associated with pandemic-related changes.
